METHODS FOR TREATING DIABETES WITH EXTENDED RELEASE FORMULATIONS OF GLP-1 RECEPTOR AGONISTS
The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CIRINCIONE, BRENDA B ZIERHUT, MATTHEW L |
| description | The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.
La présente invention concerne des procédés pour traiter le diabète, traiter le surpoids, traiter l'obésité, réduire le poids corporel, traiter les maladies cardiovasculaires, traiter les maladies de stéatose hépatique, traiter les maladies gastro-intestinales, et traiter les maladies neurodégénératives par l'administration une fois par mois de formulations pharmaceutiques contenant un véhicule non aqueux et des agonistes de récepteur GLP-1 qui produisent des niveaux de concentration plasmatique thérapeutiquement efficaces des agonistes de récepteur GLP-1 sur une période d'un mois. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2012177929A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2012177929A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2012177929A23</originalsourceid><addsrcrecordid>eNqNzLEKwjAUheEuDqK-wwXngolD6Rib2ySQ5pbmSgWHUiROooX6_ljBB3A6w_9x1tm1QbakI9TUAXeo2AUD2qkTMkboHVvAC2PQqKFDjyri1zZnv1AKEagG49tcLLXClpcbZSi4yHGbre7jY067326yfY1c2TxNryHN03hLz_QeepIHIUVRlLJU8vif-gBPwDMR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS FOR TREATING DIABETES WITH EXTENDED RELEASE FORMULATIONS OF GLP-1 RECEPTOR AGONISTS</title><source>esp@cenet</source><creator>CIRINCIONE, BRENDA B ; ZIERHUT, MATTHEW L</creator><creatorcontrib>CIRINCIONE, BRENDA B ; ZIERHUT, MATTHEW L</creatorcontrib><description>The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.
La présente invention concerne des procédés pour traiter le diabète, traiter le surpoids, traiter l'obésité, réduire le poids corporel, traiter les maladies cardiovasculaires, traiter les maladies de stéatose hépatique, traiter les maladies gastro-intestinales, et traiter les maladies neurodégénératives par l'administration une fois par mois de formulations pharmaceutiques contenant un véhicule non aqueux et des agonistes de récepteur GLP-1 qui produisent des niveaux de concentration plasmatique thérapeutiquement efficaces des agonistes de récepteur GLP-1 sur une période d'un mois.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121227&DB=EPODOC&CC=WO&NR=2012177929A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121227&DB=EPODOC&CC=WO&NR=2012177929A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CIRINCIONE, BRENDA B</creatorcontrib><creatorcontrib>ZIERHUT, MATTHEW L</creatorcontrib><title>METHODS FOR TREATING DIABETES WITH EXTENDED RELEASE FORMULATIONS OF GLP-1 RECEPTOR AGONISTS</title><description>The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.
La présente invention concerne des procédés pour traiter le diabète, traiter le surpoids, traiter l'obésité, réduire le poids corporel, traiter les maladies cardiovasculaires, traiter les maladies de stéatose hépatique, traiter les maladies gastro-intestinales, et traiter les maladies neurodégénératives par l'administration une fois par mois de formulations pharmaceutiques contenant un véhicule non aqueux et des agonistes de récepteur GLP-1 qui produisent des niveaux de concentration plasmatique thérapeutiquement efficaces des agonistes de récepteur GLP-1 sur une période d'un mois.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzLEKwjAUheEuDqK-wwXngolD6Rib2ySQ5pbmSgWHUiROooX6_ljBB3A6w_9x1tm1QbakI9TUAXeo2AUD2qkTMkboHVvAC2PQqKFDjyri1zZnv1AKEagG49tcLLXClpcbZSi4yHGbre7jY067326yfY1c2TxNryHN03hLz_QeepIHIUVRlLJU8vif-gBPwDMR</recordid><startdate>20121227</startdate><enddate>20121227</enddate><creator>CIRINCIONE, BRENDA B</creator><creator>ZIERHUT, MATTHEW L</creator><scope>EVB</scope></search><sort><creationdate>20121227</creationdate><title>METHODS FOR TREATING DIABETES WITH EXTENDED RELEASE FORMULATIONS OF GLP-1 RECEPTOR AGONISTS</title><author>CIRINCIONE, BRENDA B ; ZIERHUT, MATTHEW L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2012177929A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2012</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>CIRINCIONE, BRENDA B</creatorcontrib><creatorcontrib>ZIERHUT, MATTHEW L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CIRINCIONE, BRENDA B</au><au>ZIERHUT, MATTHEW L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS FOR TREATING DIABETES WITH EXTENDED RELEASE FORMULATIONS OF GLP-1 RECEPTOR AGONISTS</title><date>2012-12-27</date><risdate>2012</risdate><abstract>The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.
La présente invention concerne des procédés pour traiter le diabète, traiter le surpoids, traiter l'obésité, réduire le poids corporel, traiter les maladies cardiovasculaires, traiter les maladies de stéatose hépatique, traiter les maladies gastro-intestinales, et traiter les maladies neurodégénératives par l'administration une fois par mois de formulations pharmaceutiques contenant un véhicule non aqueux et des agonistes de récepteur GLP-1 qui produisent des niveaux de concentration plasmatique thérapeutiquement efficaces des agonistes de récepteur GLP-1 sur une période d'un mois.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2012177929A2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | METHODS FOR TREATING DIABETES WITH EXTENDED RELEASE FORMULATIONS OF GLP-1 RECEPTOR AGONISTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T13%3A53%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CIRINCIONE,%20BRENDA%20B&rft.date=2012-12-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2012177929A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |